Lupin Diagnostics receives NABL accreditation for all Greenfield Labs
Mumbai: Lupin Diagnostics Limited, a wholly owned subsidiary of global
pharma major Lupin Limited, has received 100 percent National Accreditation Board for
Testing and Calibration Laboratories (NABL) accreditation across all its greenfield labs.
“This accreditation is a testament to the team’s dedication to patient care and our mission to
promote healthier lives. The 27 greenfield labs across the country ensure timely and accurate
reporting. Our goal is to empower doctors and patients with evidence-based diagnostics,” said
Ravindra Kumar, CEO, Lupin Diagnostics. “We remain committed to enhancing healthcare through
continuous improvement and innovation.”
promote healthier lives. The 27 greenfield labs across the country ensure timely and accurate
reporting. Our goal is to empower doctors and patients with evidence-based diagnostics,” said
Ravindra Kumar, CEO, Lupin Diagnostics. “We remain committed to enhancing healthcare through
continuous improvement and innovation.”
Among its recent accolades, Lupin Diagnostics received the prestigious titles of ‘Patient-Centric
Diagnostic Laboratories Company of the Year’ at the IHW 3rd Patients First Award 2024, ‘Emerging
Diagnostics Chain of the Year’ at the Diagnostics Innovation and Excellence Award 2024 by Voice of
Healthcare, and ‘Pathology Lab of the Year’ (National Category) at the ET Healthcare Awards in 2022
and 2024.
Diagnostic Laboratories Company of the Year’ at the IHW 3rd Patients First Award 2024, ‘Emerging
Diagnostics Chain of the Year’ at the Diagnostics Innovation and Excellence Award 2024 by Voice of
Healthcare, and ‘Pathology Lab of the Year’ (National Category) at the ET Healthcare Awards in 2022
and 2024.
Lupin Diagnostics Limited is a wholly owned subsidiary of Lupin Limited. Founded in December 2021, the
company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to
doctors, patients, and consumers.
company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to
doctors, patients, and consumers.
The company began its journey by establishing a state-of-the-art 45,000 sq. ft. National Reference Laboratory
located in Navi Mumbai. Over 3000 tests including routine and high-end tests are offered under
Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, histopathology, immunology,
and routine biochemistry).
Currently, LDL operates in West, South, East and Central zones.
located in Navi Mumbai. Over 3000 tests including routine and high-end tests are offered under
Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, histopathology, immunology,
and routine biochemistry).
Currently, LDL operates in West, South, East and Central zones.
Its parent company, Lupin Limited is a global pharmaceutical company headquartered in Mumbai, India, with products distributed in
over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations,
complex generics, biotechnology products, and active pharmaceutical ingredients. It has a strong position in India and the U.S. across
multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal,
central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research
centers globally.
over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations,
complex generics, biotechnology products, and active pharmaceutical ingredients. It has a strong position in India and the U.S. across
multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal,
central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research
centers globally.
Facebook Comments